> During the probiotics phase participants consumed Supherb Bio-25 bi-daily, which is described by the manufacturer to contain at least 25 billion active bacter

> During the probiotics phase participants consumed Supherb Bio-25 bi-daily, which is described by the manufacturer to contain at least 25 billion active bacteria of the following strains: B. bifidum, L. rhamnosus, L. lactis, L. casei, B. breve, S. thermophilus, B. longum sbsp. longum, L. paracasei, L. plantarum and B. longum sbsp. infantis. According to the manufacturer, the pills underwent double coating to ensure their survival under stomach acidity and their proliferation in the intestines. Validation of the aforementioned strains quantity and viability was performed as part of the study. https://www.cell.com/cell/fulltext/S0092-8674(18)31102-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867418311024%3Fshowall%3Dtrue#secsectitle0075 https://www.cell.com/cell/fulltext/S0092-8674(18)31102-4?_re...